Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | LY4337713 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on LY4337713, a putative radioligand targeting FAP (Oct 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| LY4337713 | LY-4337713|LY 4337713 | Limited information is currently available on LY4337713, a putative radioligand targeting FAP (Oct 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07213791 | Phase I | LY4337713 | A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT) | Recruiting | USA | NLD | 0 |